Charles Homcy, M.D.
“New understanding of human genetics has given us the opportunity to transform drug discovery.”
Charles has significant experience building and leading successful biotech companies, and focuses on the formation of companies discovering and developing novel therapeutic approaches.
Charles has been a clinical professor of medicine at the University of California, San Francisco Medical School and an attending physician at the San Francisco VA Medical Center since 1997. Prior to Third Rock, Charles co-founded Portola Pharmaceuticals, a company focusing on drugs used in the treatment of thrombosis and hematological malignancies, and served as president and chief executive officer.